Bond markets kept grinding higher today, testing levels this market has not seen in decades. One chipmaker gave investors a reason to smile even as a legacy aerospace name gave them a reason to wince. 

Stick around; tonight’s session has more nuance than the headline numbers let on.

Capital gains taxes can take a bigger bite out of your profits than expected.

Fortunately, some deductions may help reduce the impact — including:

Because rules and eligibility vary, many investors turn to fiduciary financial advisors for guidance.

Find an Advisor Match

You’re looking at one insurance business growing revenue by double digits despite a major stock-price reset and one semiconductor giant enjoying extraordinary AI demand. Elite Trade Club Insider readers are seeing two very different capital decisions: a major shareholder just bought $7.1 million of the beaten-down name, while a co-founder's investment vehicles sold $250 million of stock from the AI winner.

Every day, insiders and institutions move millions before the market catches on. We surface the data behind those moves before the rest of the market sees it.

A subscription gets you:

$25/mo or $250/yr. 30-day money back guarantee. Cancel anytime. Founding member pricing: lock in $25/mo before we raise it.

Treasury yields pushed toward a fresh nineteen-year high today, closing in on levels not seen in nearly a quarter century, while oil stayed choppy as traders weighed conflicting signals on Iran negotiations and Saudi Arabia resumed loadings from its repaired Yanbu pipeline. 

Nvidia grabbed the spotlight after unveiling a record 150 billion buyback, with CEO Jensen Huang framing it as a return of cash from the biggest infrastructure buildout in history.

Boeing slid after confirming a software glitch tied to its next jet model, while MongoDB’s stock slumped after its CEO announced plans to leave for a new AI venture at Meta. A heavy news day dressed up as a quiet one.

Rank One Computing secured its largest federal contract yet after the Justice Department awarded it an eight-year, $64.3 million agreement, giving the Denver-based Vision AI company a long-term role managing digital evidence used in federal prosecutions.

Cerebras is adding another major AI infrastructure customer after Gimlet Labs ordered roughly 100 megawatts of its computing systems, with the cloud startup planning to deploy the hardware for high-speed inference workloads beginning in 2027.

Kodiak Sciences cleared a major late-stage hurdle in wet AMD after both treatments in its DAYBREAK Phase 3 study met their primary endpoints, with Zenkuda matching aflibercept while supporting six-month dosing for most enrolled patients.

Mirum’s hepatitis candidate delivered positive Phase 3 results after brelovitug reduced virus levels and normalized liver enzymes, positioning the company to seek approval for a treatment it believes can eventually generate at least $1 billion in peak sales.

Citi is taking its tokenized payment network into two additional markets after expanding Citi Token Services into Japan and the United Arab Emirates, enabling corporate clients to move dollar and euro deposits across seven markets around the clock.

Fiserv is facing pressure for a much deeper operational overhaul as Jana Partners pushes the payments company to double planned cost reductions and adopt Palantir software, targeting faster modernization after a prolonged decline in market value.

This report focuses on a narrow group of stocks identified through a detailed screening process.

Analysts apply a combination of metrics to narrow down potential opportunities.

Past selections have shown strong momentum, but no outcomes are guaranteed.

The newest edition is now open for access.

Get the report now.

*This free resource is being sent by Zacks. We identify investment resources you may choose to use in making your own decisions. Use of this resource is subject to the Zacks Terms of Service.
*Past performance is no guarantee of future results. Investing involves risk. This material does not constitute investment, legal, accounting, or tax advice. Zacks Investment Research is not a licensed dealer, broker, or investment adviser.

Carnival is bringing conversational AI directly into cruise planning after Princess Cruises launched a native application inside ChatGPT, allowing travelers to compare prices, itineraries, ships, destinations, and shore excursions without leaving their existing conversation.

Clorox is combining two professional-cleaning operations under one business with the launch of Clorox Purell ProCare, creating a unified sales and distribution platform for healthcare and commercial customers following its acquisition of Purell manufacturer GOJO.

GOWell has entered the public market after completing its SPAC combination and beginning Nasdaq trading under the symbol GOW, giving the energy-technology provider greater access to capital for well logging, distributed sensing, and international expansion.

Harvard Ave has found a merger target in energy infrastructure after signing a business-combination agreement with OAG International, which has completed more than 200 specialized pipeline projects across 27 countries and plans to list the combined company on Nasdaq.

Kodiak Sciences [KOD] $89.92 (+177.96%)

Kodiak Sciences nearly tripled after its experimental eye drug Zenkuda matched Regeneron’s blockbuster Eylea in a Phase 3 trial for wet macular degeneration, with more than half of patients going six months between injections instead of the usual two.

The company now plans to seek FDA approval by the fourth quarter. This is the kind of head-to-head data biotech investors dream about.

Lifecore Biomedical [LFCR] $6.52 (+55.24%)

Lifecore Biomedical jumped after agreeing to be acquired by Webster Equity Partners, giving shareholders a clean exit at a premium after a stretch of uncertainty around the company’s direction.

Buyout announcements tend to remove the guesswork investors hate most. The deal effectively puts a floor under the stock for anyone still holding on.

ClearOne [CLRO] $5.10 (+47.83%)

ClearOne bounced back hard after a rough stretch tied to weak recent financials, the kind of snapback rally that often follows when a beaten-down name gets oversold.

There is no fresh positive headline attached today, just traders stepping in after the selling looked overdone. Thin float names like this one can swing just as violently on the way back up.

ITG [ITG] $7.07 (-32.59%)

ITG tumbled with no distinct headline attached, the kind of sharp reversal that tends to hit small industrial names once a crowded trade starts to unwind.

The stock carries a strong buy rating, which made today’s drop sting even more for anyone who bought the dip recently. Sometimes momentum just runs out of road without warning.

Adicet Bio [ACET] $6.35 (-29.60%)

Adicet Bio slid with no fresh negative catalyst in sight, a pullback that looks more like profit-taking after a period of relative strength for the cell therapy developer. The underlying pipeline story has not shifted overnight.

Biotech names this size can swing hard on sentiment alone, and today sentiment simply turned.

AIFU [AIFU] $8.81 (-26.71%)

AIFU dropped as short interest in the name surged more than one hundred percent over the past week, a sign that bearish bets had been quietly piling up before today’s slide.

There is no single fresh headline explaining the move, just a stock that had become an increasingly popular target for sellers. The pressure finally showed up on the tape.

November 1910. Seven of America's most powerful bankers met in secret on Jekyll Island, Georgia, to design the Federal Reserve.

Since 1913, the dollar has lost over 96% of its purchasing power.

Tan Gera, CFA©, an ex-Wall Street banker, warns CBDCs could be the next step: every transaction tracked, every account programmable.

His free presentation shows investors with $50k+ how decentralized finance offers a way out.

Watch it here

*This content is for educational purposes only. The opinions expressed are from DM Intelligence LLC, doing business as Decentralized Masters, who are not licensed financial advisors or registered investment advisors. The reader acknowledges that DM Intelligence LLC is not responsible for any losses, direct or indirect, resulting from the use of this information, including errors, omissions, or inaccuracies.

*Results are not typical and will vary. Success with digital currencies requires time, effort, and involves substantial risk including total loss of investment. Past performance does not indicate future results. All investments are at your own risk.

*Please click here if you would like to unsubscribe.

That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback!

Thanks for reading. I'll see you at the next open! 

Best Regards,
— Adam G.
Elite Trade Club

Click here to get our daily newsletter straight to your cell for free.

P.S. Just like this newsletter, it's 100% free*, and you can stop at any time by replying STOP.